特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の細胞診断市場の分析

Global Tissue Diagnostics Market Research and Forecast, 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 425938
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
世界の細胞診断市場の分析 Global Tissue Diagnostics Market Research and Forecast, 2018-2023
出版日: 2018年03月06日 ページ情報: 英文
概要

当レポートでは、世界の細胞診断市場について調査分析し、市場影響要因、地域別の規制・政策、市場決定要因、収益予測、主要企業のプロファイルや最近の動向など、体系的な情報を提供しています。

第1章 レポートサマリー

第2章 市場概要と考察

  • ギャップ分析
  • 歴史的分析
  • パラメーター分析
  • アナリストの考察
  • 規制

第3章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第4章 体外診断薬 (IVD) 市場分析

第5章 市場区分

  • 技術別
  • 疾患別
  • 製品別
  • エンドユーザー別

第6章 競合情勢

  • 市場シェア分析
  • 主要企業分析

第7章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第8章 企業プロファイル

  • ROCHE HOLDINGS AG
  • BIOGENEX LABORATORIES
  • BIO SB.
  • CELL SIGNALLING TECHNOLOGY, INC.
  • QIAGEN
  • BECTON DICKINSON & COMPANY
  • ALERE
  • DIAGENIC
  • STRYKER
  • BIOMERIUX
  • PROMETHEUS LABORATORIES
  • AGILENT TECHNOLOGIES
  • DANAHER CORPORATION
  • GE HEALTHCARE
  • PHILIPS
  • SIEMENS
  • JOHNSON & JOHNSON
  • QUEST DIAGNOSTIC
  • AXXIN
  • CARIS LIFE SCIENCES
  • SINGULEX
  • TECO DIAGNOSTICS
  • RIBOMED
  • SIGNAL GENETICS
  • TRINITY BIOTECH
  • GRIFOLS DIAGNOSTIC SOLUTIONS INC
  • NOVODIAX
  • BIOCEPT
  • EUROGENTEC
図表

List of Tables

  • TABLE # 1 GLOBAL TISSUE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS, BY REGION 2017-2023 ($MILLION)
  • TABLE # 2 KEY FACTS ABOUT CANCER BY W.H.O.
  • TABLE # 3 BENEFITS PROVIDED BY THE PERSONALIZED HEALTHCARE
  • TABLE # 4 FACTS AT A GLANCE: THE BURDEN OF CANCER IN EUROPE
  • TABLE # 5 FACTS AT A GLANCE: THE BURDEN OF CANCER IN THE UNITED STATES
  • TABLE # 6 RECENT FDA APPROVALS
  • TABLE # 7 EFFECTS OF EARLY DETECTION AND TREATMENT OF CANCER IN THE UNITED STATES IN 2017 COMPARED TO LAST TWO DECADES
  • TABLE # 8 FEATURES OF NEW AND TECHNICALLY ADVANCED DIAGNOSTIC AND TREATMENT METHODS
  • TABLE # 9 GOVERNMENT SUPPORT FOR CANCER RESEARCH
  • TABLE # 10 RESEARCH AND DEVELOPMENT BY TISSUE DIAGNOSTICS
  • TABLE # 11 COST OF SELECTED DRUGS IN CANCER THERAPY
  • TABLE # 12 RECENT INITIATIVES OF NATIONAL CANCER INSTITUTE CLINICAL TRIALS WORKING GROUPS TO OPTIMIZE THE CLINICAL TRIAL SYSTEM
  • TABLE # 13 SOME BENEFICIAL COLLABORATION IN THE INDUSTRY
  • TABLE # 14 GLOBAL TISSUE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023
  • TABLE # 15 GLOBAL IMMUNOHISTOCHEMISTRY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 16 GLOBAL IN SITU HYBRIDIZATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 17 GLOBAL DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 18 KEY EXAMPLES OF SPECIAL STAINS
  • TABLE # 19 GLOBAL SPECIAL STAINING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 20 REQUIREMENTS OF HEMATOXYLIC & EOSIN STAIN TECHNOLOGY
  • TABLE # 21 H&E STAIN MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 22 GLOBAL TISSUE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS 2017-2023 ($ MILLION)
  • TABLE # 23 GLOBAL LYMPHOMA MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
  • TABLE # 24 GLOBAL GASTRIC CANCER MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
  • TABLE # 25 GLOBAL LYMPHOMA MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
  • TABLE # 26 GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
  • TABLE # 27 GLOBAL NON-SMALL CELL LUNG CARCINOMA MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
  • TABLE # 28 GLOBAL INSTRUMENT MARKET RESEARCH AND ANALYSIS, 2017-2023
  • TABLE # 29 GLOBAL INSTRUMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 30 GLOBAL SLIDE STAINING SYSTEMS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 31 CURRENTLY AVAILABLE WHOLE-SLIDE IMAGING SCANNERS
  • TABLE # 32 GLOBAL SCANNERS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 33 GLOBAL TISSUE PROCESSING SYSTEMS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 34 GLOBAL OTHER INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 35 GLOBAL CONSUMABLES MARKET RESEARCH AND ANALYSIS, 2017-2023
  • TABLE # 36 GLOBAL CONSUMABLES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 37 GLOBAL ANTIBODY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 38 APPROVED KITS FOR TISSUE DIAGNOSTICS
  • TABLE # 39 GLOBAL KITS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 40 GLOBAL REAGENTS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 41 GLOBAL PROBES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023
  • TABLE # 42 GLOBAL TISSUE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS, BY END USER 2017-2023 , ($ MILLION)
  • TABLE # 43 HIGH-TECH FEATURES INCLUDED IN TODAY'S TOP CANCER HOSPITALS
  • TABLE # 44 AVERAGE COST OF CANCER TREATMENTS
  • TABLE # 45 BENEFITS OF TISSUE DIAGNOSTICS FOR THE HOSPITALS
  • TABLE # 46 HOSPITALS STRESSING ON THE APPLICATION OF TISSUE DIAGNOSTICS FOR CANCER TREATMENTS
  • TABLE # 47 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023 , ($ MILLION)
  • TABLE # 48 GLOBAL PHARMACEUTICALS MARKET RESEARCH AND ANALYSIS, 2017-2023 , ($ MILLIONS)
  • TABLE # 49 REGULATIONS AFFECTING THE RESEARCH AND DEVELOPMENT ACTIVITIES CARRIED BY THE RESEARCH INSTITUTES.
  • TABLE # 50 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2017-2023 , ($ MILLIONS)
  • TABLE # 51 GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS, 2017-2023 , ($ MILLIONS)
  • TABLE # 52 GLOBAL OTHER RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS, 2017-2023 , ($ MILLIONS)
  • TABLE # 53 RECENT ACTIVITIES OF DANAHER CORPORATION
  • TABLE # 54 RECENT ACTIVITIES OF ROCHE HOLDING AG
  • TABLE # 55 RECENT ACTIVITIES OF QIAGEN
  • TABLE # 56 RECENT ACTIVITIES OF BIOCEPT
  • TABLE # 57 GLOBAL TISSUE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
  • TABLE # 58 LUNG CANCER STATISTICS, CANADA, 2015-2017
  • TABLE # 59 MOLECULAR SOLUTIONS FOR TISSUE DIAGNOSTICS
  • TABLE # 60 OTHER KEY REGIONS AT A GLANCE
  • TABLE # 61 KEY MARKETS IN REST OF THE WORLD

List of Figures

  • FIGURE # 1 MARKET SHARE BY GEOGRAPHY (%) 2015
  • FIGURE # 2 GLOBAL TISSUE DIAGNOSTIC MARKET (%) BY TECHNOLOGY, 2017
  • FIGURE # 3 GLOBAL TISSUE DIAGNOSTIC MARKET (%) BY DISEASES, 2017
  • FIGURE # 4 GLOBAL TISSUE DIAGNOSTIC MARKET (%) BY PRODUCTS, 2017
  • FIGURE # 5 PATIENTS DYEING DUE TO UNTREATED PAIN IN DEVELOPED VERSUS DEVELOPING COUNTRIES, 2017
  • FIGURE # 6 COMMONLY USED MARKERS
  • FIGURE # 7 CHARACTERISTICS OF NUMEROUS METHODS OF IN SITU HYBRIDIZATION
  • FIGURE # 8 APPLICATIONS OF IN SITU HYBRIDIZATION
  • FIGURE # 9 GASTRIC CANCERS BY FREQUENCY OF OCCURRENCE
  • FIGURE # 10 PROCESS OF TISSUE PROCESSING
  • FIGURE # 11 GLOBAL ONCOLOGY DRUG SPENDING 2017 ($ BILLION)
  • FIGURE # 12 MARKET SHARE BY ACTIVITIES
  • FIGURE # 13 KEY STRATEGIES OF LEADING PLAYERS
  • FIGURE # 14 PRODUCT LAUNCH/APPROVAL ANALYSIS
  • FIGURE # 15 PARTNERSHIP AND COLLABORATION ANALYSIS
  • FIGURE # 16 MERGER & ACQUISITION ANALYSIS
  • FIGURE # 17 NORTH AMERICA TISSUE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS, 2017-2023 , ($ MILLION)
  • FIGURE # 18 EUROPE TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 19 REST OF THE WORLD TISSUE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
目次
Product Code: MD-1204

Tissue Diagnostics Market is expected to grow with a CAGR 7.7% during 2018-2023. Need for more accurate diagnosis in cases of cancer has resulted in development more advanced diagnostic technologies such as tissue diagnostics. Cancer is a fatal disease and it is prevalent across the globe with huge economic burden in emerging and low-middle income group countries. It has considerable presence in developed and developing economies such as US, UK, Spain, China, India and Korea. Tissue diagnosis includes Haematoxylin & Eosin (H&E) Stain, Immunohistochemistry (IHC) Test, Fluorescent in Situ Hybridization (FISH) Test, Silver in Situ Hybridization (SISH) Test, Pathology and other stain tests. These diagnostic services are widely available and due to technological advancement, innovation and efficient results these diagnostic devices are in huge demand.

Tissue diagnostics market on the basis of geographical regions is analysed as North America, Europe, APAC, and Rest of the world. Asia Pacific generates highest revenues across the globe due to high prevalence of cancer. APAC region such as China, India, Japan and Korea are the key markets and expected to improve upon their existing diagnostic technologies. Improved healthcare spending, infrastructure and favourable government policies are the key factors which are expected to drive the APAC market. The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, pipeline analysis, strategic recommendations, key company analysis, gap analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.

The report also covers various factors that influence the market such as the government regulations, drug and device laws and regulations, regulations on clinical trials and government policies. The report also covers parametric analysis, historical analysis and tissue diagnosis which includes various test such as Haematoxylin and silver in situ hybridization test. Global tissue diagnostic market is segmented on the basis of technology, diagnosis, product, end user and geography.

The key players of global tissue diagnostic market includes Abbott Laboratories, Roche Holdings AG, Biogenex Laboratories, Bio SB, Agilent Technologies Cell Signaling Technology, Danaher Corporation, Sigma-Aldrich, Thermo Fisher Scientific, Qiagen, Becton Dickinson & company, Alere, Diagenic, Stryker, Biomeriux, Promethius Laboratories, Life Technologies, GE healthcare, Philips, Siemens, Johnson & Johnson, Quest Diagnostic, Axxin, Caris Life Sciences, Singulux, Teco Diagnostic, Ribomed, Signal Genetics and so on.

Market Segmentation

Global Tissue Diagnostics Market by Technology

Global Tissue Diagnostics Market by Disease

Global Tissue Diagnostics Market by Product

Global Tissue Diagnostics Market by End Users

RESEARCH METHODOLOGY

The market study of tissue diagnostic market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

Financial reports of companies involved in the market

Authentic Public Databases

Whitepapers, research-papers and news blogs

Company websites and their product catalogue.

Supplier Websites such as Alibaba, amazon for pricing analysis.

The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

The Report covers:

Comprehensive research methodology of Global Tissue Diagnostics Market.

This report also includes detailed and extensive market overview with Analyst insights & key market trends.

Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the Global Tissue Diagnostics Market.

Insights about market determinants which are stimulating the Global Tissue Diagnostics Market.

Detailed and extensive market segments with regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1 REPORT SUMMARY

1.1. RESEARCH METHODS AND TOOLS

1.2. MARKET BREAKDOWN

1.2.1. BY SEGMENTS

1.2.2. BY GEOGRAPHY

1.2.3. BY STAKEHOLDERS

2 MARKET OVERVIEW AND INSIGHTS

2.1. GAP ANALYSIS

2.2. HISTORICAL ANALYSIS

2.3. PARAMETRIC ANALYSIS

2.3.1. RISING INCIDENCE AND PREVALENCE RATE OF CANCER

2.3.2. EPIDEMIC OF NEURO-DEGENERATIVE DISEASES

2.3.3. RISING DIAGNOSTIC CENTERS ACROSS GEOGRAPHIES

2.3.4. RISING LABORATORIES ACROSS GEOGRAPHIES

2.3.5. HOSPITAL AND RESEARCH CENTER ON RISE

2.4. ANALYST INSIGHT

2.4.1. KEY FINDINGS AND CURRENT TRENDS

2.4.2. RECOMMENDATION

2.4.3. CONCLUSION

2.5. REGULATION

2.5.1. REGULATIONS ON CLINICAL TRIALS

2.5.1.1. UNITED STATES

2.5.1.2. EUROPEAN UNION

2.5.1.3. CHINA

2.5.1.4. INDIA

2.5.2. DRUG AND DEVICE REGULATIONS

2.5.2.1. UNITED STATES

2.5.2.2. EUROPEAN UNION

2.5.2.3. CHINA

2.5.2.4. INDIA

2.5.2.5. JAPAN

3 MARKET DETERMINANT

3.1. MOTIVATORS

3.1.1. RISE IN PERSONALIZED HEALTHCARE

3.1.2. RISING IN-VITRO DIAGNOSTICS ENABLES TISSUE DIAGNOSTIC MARKET TO GROW SIGNIFICANTLY

3.1.3. RISE IN CANCER INCIDENCE & PREVALENCE

3.1.4. FDA APPROVALS ARE ON RISE AND MAY ATTRACT OTHER BIG PLAYERS TO ENTER INTO THE TISSUE DAIGNOSTIC MARKET

3.1.5. RISE IN ADOPTION OF CANCER DIAGNOSTICS AND TREATMENT

3.1.6. TECHNOLOGICAL ADVANCEMENT IN TISSUE DIAGNOSTIC

3.1.7. DEVELOPMENT IN PROTEOMICS AND GENOMICS

3.1.8. INNOVATION IN DIAGNOSTIC AND TREATMENT

3.1.9. FAVORABLE GOVERNMENT POLICIES AND REGULATIONS

3.1.10. RESEARCH & DEVELOPMENT TO DRIVE THE TISSUE DIAGNOSTIC MARKET

3.2. RESTRAINT

3.2.1. HIGH COST OF DIAGNOSIS & TREATMENT

3.2.2. STRINGENT GOVERNMENT REGULATIONS

3.3. OPPPORTUNITY

3.3.1. COST SAVING FOR LABORATORIES DUE TO EFFICIENT TISSUE DIAGNOSTIC DEVICES

3.3.2. ADOPTION OF LAB AUTOMATION TECHNOLOGY IN TISSUE DIAGNOSTIC

3.3.3. UNTAPPED APAC REGION IS FULL OF OPPORTUNITY FOR GLOBAL TISSUE DIAGNOSTIC MARKET

3.3.4. CLINICAL TRIALS ARE PREDICTED TO INCREASE IN NEXT FEW YEARS

3.3.5. COLLABORATION AND PARTNERSHIP IN TISSUE DAIGNOSTIC MARKET

4 IN VITRO DIAGNOSTICS MARKET ANALYSIS

5 MARKET SEGMENTATION

5.1. BY TECHNOLOGY

5.1.1. IMMUNOHISTOCHEMISTRY

5.1.2. IN SITU HYBRIDIZATION

5.1.3. DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT

5.1.4. SPECIAL STAINING

5.1.5. HEMATOXYLIN & EOSIN (H&E) STAIN

5.2. BY DISEASES

5.2.1. BREAST CANCER

5.2.2. GASTRIC CANCER

5.2.3. LYMPHOMA

5.2.4. PROSTATE CANCER

5.2.5. NON-SMALL CELL LUNG CARCINOMA

5.3. BY PRODUCT

5.3.1. INSTRUMENTS

5.3.1.1. SLIDE STAINING SYSTEMS

5.3.1.2. SCANNERS

5.3.1.3. TISSUE PROCESSING SYSTEMS

5.3.1.4. OTHER PRODUCTS MARKET

5.3.2. CONSUMABLES

5.3.2.1. ANTIBODY

5.3.2.2. KITS

5.3.2.3. REAGENTS

5.3.2.4. PROBES

5.4. BY END USER

5.4.1. HOSPITALS

5.4.2. PHARMACEUTICALS

5.4.3. RESEARCH INSTITUTES

5.4.4. LABORATORIES

5.4.5. OTHER RESEARCH

6 COMPETETIVE LANDSCAPE

6.1. MARKET SHARE ANAYSIS

6.2. KEY COMPANY ANALYSIS

7 REGIONAL ANALYSIS

7.1. NORTH AMERICA

7.1.1. UNITED STATES

7.1.2. CANADA

7.2. EUROPE

7.2.1. WESTERN EUROPE

7.2.2. REST OF EUROPE

7.3. ASIA PACIFIC

7.3.1. INDIA

7.3.2. CHINA

7.3.3. JAPAN

7.3.4. REST OF ASIA PACIFIC

7.4. REST OF THE WORLD

8 COMPANY PROFILES

8.1. AGILENT TECHNOLOGIES

8.2. ALERE

8.3. AXXIN

8.4. BECTON DICKINSON & COMPANY

8.5. BIO SB.

8.6. BIOCEPT

8.7. BIOGENEX LABORATORIES

8.8. BIOMERIUX

8.9. CARIS LIFE SCIENCES

8.10. CELL SIGNALLING TECHNOLOGY, INC.

8.11. DANAHER CORPORATION.

8.12. DIAGENIC

8.13. EUROGENTEC

8.14. GE HEALTHCARE

8.15. GRIFOLS DIAGNOSTIC SOLUTIONS INC

8.16. JOHNSON & JOHNSON

8.17. NOVODIAX

8.18. PHILIPS

8.19. PROMETHEUS LABORATORIES

8.20. QIAGEN

8.21. QUEST DIAGNOSTIC

8.22. RIBOMED

8.23. ROCHE HOLDINGS AG

8.24. SIEMENS

8.25. SIGNAL GENETICS

8.26. SINGULEX

8.27. STRYKER

8.28. TECO DIAGNOSTICS

8.29. TRINITY BIOTECH